SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-19-025368
Filing Date
2019-10-09
Accepted
2019-10-09 16:51:55
Documents
1
Period of Report
2019-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 5629
  Complete submission text file 0000899243-19-025368.txt   7889
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Reporting) CIK: 0000901832 (see all company filings)

Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-39067 | Film No.: 191144807
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
AstraZeneca UK LTD (Reporting) CIK: 0001362825 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 3/A | Act: 34 | File No.: 001-39067 | Film No.: 191144808

Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-780-6356
Viela Bio, Inc. (Issuer) CIK: 0001734517 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations